There is renewed interest in the use of immunomodulatory therapies in patients with acute hypoxemic respiratory failure. Multiple investigations during the course of the pandemic demonstrated that dexamethasone administration improved mortality in patients with severe COVID-19.

The respiratory community is interested in artificial intelligence (AI) because it can improve the effectiveness of our care delivery processes. AI is a group of nonhuman techniques that utilize automated […]

Intravenous albumin is a human-derived blood product studied widely in a variety of patient populations. Despite its frequent use in critical care, few high-quality studies have demonstrated improvements in patient-important […]

A 47-year-old woman with a history of cirrhosis is admitted with an acute kidney injury and altered mental status. On the initial workup, there are no signs of infection, and […]

Bedside-focused cardiac ultrasound assessment, or cardiac point-of-care ultrasound (POCUS), has become common in intensive care units throughout the US and the world. Many clinicians argue a POCUS cardiac assessment should […]

The practice of initiating early and adequate nutrition in critically ill patients is a cornerstone of ICU management. Adequate nutrition combats the dangerous catabolic state that accompanies critical illness. A […]

Patients admitted to ICUs require modifications to their medication regimen due to their critical illness and rapidly changing clinical status. Modifications to medication regimens may include stopping home medications for […]